Industry

B&L gets FDA clearance for Bi-Blade+

Healio Optometry3h ago1 min read

Editor’s note: This is a developing news story. Please check back soon for updates.Bausch + Lomb obtained 510(k) FDA clearance for its Bi-Blade+ advanced dual-port vitrectomy cutter and Adaptive Fluidics update for the Stellaris Elite system, according to a company press release.The Bi-Blade+ allows for more efficient vitreous removal by increasing flow rate and reduces cutter vibration compared with the company’s previous device, Bi-Blade. The update to Adaptive Fluidics automatically infuses fluid into the eye during surgery by responding to surgeon vacuum commands, according to the

Read full article on Healio Optometry

AI Summary

Quick Take

Bausch + Lomb has received FDA 510(k) clearance for its Bi-Blade+ dual-port vitrectomy cutter and an updated Adaptive Fluidics system for the Stellaris Elite platform. These enhancements aim to increase vitreous removal efficiency through higher flow rates and reduced vibration while automating fluid infusion based on real-time vacuum commands.

Why It Matters

In vitreoretinal surgery, the balance between high cut rates and fluidic stability is critical for preventing retinal traction and maintaining intraocular pressure. By doubling the port access and refining the fluidics response, Bausch + Lomb is addressing the clinical need for faster procedures without compromising safety or surgeon control. This update keeps the Stellaris Elite competitive in the high-speed vitrectomy market by focusing on mechanical efficiency and automated pressure management.

Key Details

The Bi-Blade+ is an advanced dual-port vitrectomy cutter designed to increase flow rates for more efficient vitreous removal.
The new cutter design specifically targets a reduction in vibration compared to the previous generation Bi-Blade device.
The Adaptive Fluidics update for the Stellaris Elite system automates fluid infusion by responding dynamically to surgeon vacuum commands.
FDA 510(k) clearance allows for the commercial rollout of these surgical enhancements in the United States.

Practice Implications

Surgeons using the Stellaris Elite system may experience improved procedural efficiency and better chamber stability during high-vacuum maneuvers. The reduction in cutter vibration could potentially improve precision during delicate maneuvers, such as membrane peeling or peripheral shaving, where instrument stability is paramount.

Who's Affected

Retina SpecialistsVitreoretinal SurgeonsSurgical Center Administrators

What's Next

Following this FDA clearance, Bausch + Lomb is expected to roll out the Bi-Blade+ and the fluidics update to Stellaris Elite users; further details on commercial availability and specific performance data are likely to follow.

Evidence StrengthStrong

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.